Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 2Phase 1/2 2Phase 4 1Phase 2/3 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Stomatitis 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1

Interventions

Zoledronic Acid 23Bevacizumab 13nilotinib 12Docetaxel 12Paclitaxel 11Everolimus 11Letrozole 10Imatinib Mesylate 10Capecitabine 10Erlotinib Hydrochloride 9Drug Therapy 9Carboplatin 9pegfilgrastim 8enzalutamide 8Trastuzumab 7Oxycodone 7Nivolumab 7Imiquimod 7Gemcitabine 7Epoetin Alfa 7icotinib 6Rituximab 6Prednisone 6Pemetrexed 6Oxaliplatin 6Leuprolide 6Fulvestrant 6Diclofenac 6Dexamethasone 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × Fibroblast Growth Factor 7 × Clear all
NCT00352703 2014-11-03

PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation

Swedish Orphan Biovitrum

Phase 4 Completed
145 enrolled
LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡